KENSTATIN

This brand name is authorized in Nigeria.

Active ingredients

The drug KENSTATIN contains one active pharmaceutical ingredient (API):

1	Nystatin UNII BDF1O1C72E - NYSTATIN
	Nystatin is an antifungal antibiotic active against a wide range of yeasts and yeast-like fungi, including Candida albicans.
	Read more about Nystatin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-4776	Suspension	Kenstatin Oral Suspension SUSP 100,000 IU/mL	Each mL of oral suspension contains: Nystatin 100,000 IU	16/12/2021
B4-7914	Tablet	Kenstatin Tablets TAB 500,000 IU 2 x 10's (in blisters)	Film Coated Tablet. Brown colored, round shaped, biconvex, film coated tablet having both sides plain packed in blister strip	31/01/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07AA02	Nystatin	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AA Antibiotics
Discover more medicines within A07AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-4776, B4-7914